41 – 50 of 88
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
The whistleblowing drama behind Astellas’s suspension from the ABPI
(
- Contribution to journal › Letter
- 2018
-
Mark
Explaining biological depression theories
(
- Contribution to journal › Letter
-
Mark
Let the drugs lead the way! : On the unfolding of a research programme in psychiatry
(
- Contribution to journal › Article
-
Mark
Pharmaceutical lobbying and pandemic stockpiling of Tamiflu: a qualitative study of arguments and tactics
(
- Contribution to journal › Article
-
Mark
Categorical and anti-categorical approaches to US racial/ethnic groupings: revisiting the National 2009 H1N1 Flu Survey (NHFS)
(
- Contribution to journal › Article
-
Mark
Disclosure of payments by pharmaceutical companies to healthcare professionals in the United Kingdom: analysis of the Association of the British Pharmaceutical Industry’s Disclosure UK database, 2015 and 2016 cohorts
(
- Contribution to journal › Article
-
Mark
Regulatory scientists' work has important ramifications for public health and should be open to public scrutiny
(
- Contribution to journal › Letter
-
Mark
Overuse of methylphenidate : an analysis of Swedish pharmacy dispensing data
(
- Contribution to journal › Article
-
Mark
Sunshine Policies and Murky Shadows in Europe: Disclosure of Pharmaceutical Industry Payments to Health Professionals in Nine European Countries
(
- Contribution to journal › Article
-
Mark
Sociodemographic patterns in pharmacy dispensing of medications for erectile dysfunction in Sweden
(
- Contribution to journal › Article